Physician

Joseph L Potz, M.D.

According to 2025 Medicare claims, Joseph Potz, M.D. (NPI: 1578572962) practices hematology/oncology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is ALLIANCE CANCER SPECIALISTS P.C. (NPI: 1487923686; TIN: 452552343) and primary practice location at 19044-2374.

Potz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 830 traditional Medicare patients, billed 211,572 HCPCS/CPT codes, and received $3,189,114 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,201 prescription claims across 240 beneficiaries totaling $4,606,617 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 11 claims. Open Payments data shows 199 records totaling $1,398,982. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,198,265 to $3,189,114. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $962,641 to $4,606,617. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $8,357 and ending at $2,664.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	457	125,005	$1,198,265
2016	531	164,527	$1,458,338
2017	523	149,229	$1,780,911
2018	546	165,358	$1,772,152
2019	636	168,843	$2,002,569
2020	617	193,310	$2,054,650
2021	596	160,240	$1,662,152
2022	665	188,452	$1,890,867
2023	642	153,477	$2,028,760
2024	830	211,572	$3,189,114

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	90	573	$962,641
2016	89	547	$890,445
2017	96	609	$716,852
2018	116	643	$671,009
2019	123	782	$1,534,823
2020	121	801	$2,575,168
2021	123	777	$2,458,807
2022	126	786	$2,403,478
2023	132	755	$2,265,369
2024	240	1,201	$4,606,617

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	152	$10,380
2016	N/R	122	$6,589
2017	N/R	137	$5,703
2018	N/R	147	$8,900
2019	N/R	146	$7,883
2020	N/R	74	$3,647
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$233

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	378	734	$109
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	119	218	$52
96375	Injection of additional new drug or substance into vein	91	303	$13
96372	Injection of drug or substance under skin or into muscle	157	451	$12
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	646	1,734	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	74	2,240	$1,170,301
Calquence	Acalabrutinib Maleate	49	1,470	$768,255
Ojjaara	Momelotinib Dihydrochloride	16	480	$424,805
Lenalidomide	Lenalidomide	25	700	$395,131
Jakafi	Ruxolitinib Phosphate	17	510	$277,949

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	11	$233

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$335	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	185	$1,398,647	BeiGene, Ltd.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph L. Potz, M.D.?

Tedicare shows public-source Medicare data for Joseph L. Potz, M.D. (NPI 1578572962), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph L. Potz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joseph L. Potz, M.D.?

Joseph L. Potz, M.D. is linked to ALLIANCE CANCER SPECIALISTS P.C. (billing NPI 1487923686) in the available physician profile data.

Does Joseph L. Potz, M.D. have Open Payments data?

Joseph L. Potz, M.D. has 199 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.